Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Zhong, Guocheng ^a   Cheng, Xiaoming ^a   Long, Haixia ^a   He, Luhang ^a   Qi, Wei ^a   Xiang, Tong ^a   Zhao, Zhongquan ^a   Zhu, Bo ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD8+ T lymphocyte; Immune function; Memory T cell; microRNA 15b

Indexed keywords

CD69 ANTIGEN; DEATH EFFECTOR DOMAIN CONTAINING DNA BINDING PROTEIN; DNA BINDING PROTEIN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 2; MICRORNA 15B; UNCLASSIFIED DRUG;

ACTIVATION INDUCED CELL DEATH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEATH EFFECTOR DOMAIN CONTAINING GENE; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; LEWIS CARCINOMA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TUMOR MICROENVIRONMENT; UPREGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MICE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84875177704     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-71     Document Type: Article

References (36)

1. Franks HA, Wang Q, Patel PM. New anticancer immunotherapies. Anticancer Res 2012, 32(7):2439-2453.
2. Hervas-Stubbs S, Mancheño U, Riezu-Boj JI, Larraga A, Ochoa MC, Alignani D, Alfaro C. CD8 T Cell Priming in the Presence of IFN-α Renders CTLs with Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy. J Immunol 2012, 189(7):3299-3310. 10.4049/jimmunol.1102495, 22925929.
3. Abastado JP. The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumor. Cancer Res 2012, 72(9):2159-2161. 10.1158/0008-5472.CAN-11-3538, 22549945.
4. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, Yoshimura A. Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses. Cell 2010, 142(6):914-929. 10.1016/j.cell.2010.08.012, 3049116, 20850013.
5. Lykken EA, Li QJ. MicroRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells. Immunol Res 2011, 49(1-3):87-96.
6. Ohno M, Natsume A, Wakabayashi T. Cytokine therapy. Adv Exp Med Biol 2012, 746:86-94. 10.1007/978-1-4614-3146-6_7, 22639161.
7. Shirasu N, Kuroki M. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes. Anticancer Res 2012, 32(6):2377-2383.
8. Morisaki T, Onishi H, Katano M. Cancer immunotherapy using NKG2D and DNAM-1 systems. Anticancer Res 2012, 32(6):2241-2247.
9. Tsitsiou E, Lindsay MA. MicroRNAs and the immune response. Curr Opin Pharmacol 2009, 9(4):514-520. 10.1016/j.coph.2009.05.003, 2742742, 19525145.
10. Lu LF, Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009, 127(3):291-298. 10.1111/j.1365-2567.2009.03092.x, 2712098, 19538248.
11. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation 2010, 90(2):105-112. 10.1097/TP.0b013e3181e913c2, 3094098, 20574417.
12. Liston A, Linterman M, Lu LF. MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol 2010, 30(3):339-346. 10.1007/s10875-010-9378-5, 20191314.
13. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008, 9(8):839-845. 10.1038/ni.f.209, 18645592.
14. Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y, Zhang J. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2010, 12(3):R81-R92. 10.1186/ar3006, 2911863, 20459811.
15. Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L, Xu N. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T- cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 2010, 126(3):581-589. 10.1016/j.jaci.2010.05.045, 20673989.
16. Sasaki K, Kohanbash G, Hoji A, Sasaki K, Kohanbash G, Hoji A, Ueda R, McDonald HA, Reinhart TA, Martinson J. miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. J Transl Med 2010, 8:17. 10.1186/1479-5876-8-17, 2836279, 20167088.
17. Almanza G, Fernandez A, Volinia S, Cortez-Gonzalez X, Croce CM, Zanetti M. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One 2010, 5(6):e11243. 10.1371/journal.pone.0011243, 2889817, 20582165.
18. Jindra PT, Bagley J, Godwin JG, Iacomini J. Costimulation- dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting pten. J Immunol 2010, 185(2):990-997. 10.4049/jimmunol.1000793, 3004219, 20548023.
19. Li Z, Wu F, Brant SR, Kwon JH. IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J Immunol 2011, 186(11):6182-6190. 10.4049/jimmunol.1000917, 3133967, 21508257.
20. Liu Y, Wang X, Jiang J, Cao Z, Yang B, Cheng X. Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 2011, 48(9-10):1084-1090.
21. Stittrich AB, Haftmann C, Sgouroudis E, Kühl AA, Hegazy AN, Panse I, Riedel R. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010, 11(11):1057-1062. 10.1038/ni.1945, 20935646.
22. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010, 184(12):6773-6781. 10.4049/jimmunol.0904060, 20483747.
23. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N. MiRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2007, 2(10):e1020. 10.1371/journal.pone.0001020, 2000354, 17925868.
24. Xue Q, Guo ZY, Li W, Wen WH, Meng YL, Jia LT, Wang J. Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c. Mol Immunol 2011, 48(4):592-599. 10.1016/j.molimm.2010.10.021, 21112091.
25. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115(2):265-273. 10.1182/blood-2009-06-225987, 19965651.
26. Steiner DF, Thomas MF, Hu JK, Yang ZY, Babiarz JE, Allen CD, Matloubian M. MicroRNA-29 regulates T-box transcription factors and interferon-gamma production in helper T cells. Immunity 2011, 35(2):169-181. 10.1016/j.immuni.2011.07.009, 3361370, 21820330.
27. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, Yin H. MicroRNA-126 regulates DNA methylation in CD4(+) T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011, 63(5):1376-1386. 10.1002/art.30196, 21538319.
28. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA. Selective mRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008, 205(9):1983-1991. 10.1084/jem.20080707, 2526194, 18725525.
29. Jiang S, Li C, Olive V, Lykken E, Feng F, Sevilla J, Wan Y. Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible treg differentiation. Blood 2011, 118(20):5487-5497. 10.1182/blood-2011-05-355644, 3217351, 21972292.
30. Pauley KM, Chan EK. MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci 2008, 1143(1):226-239. 10.1196/annals.1443.009, 19076353.
31. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ, Birolo RS. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 2011, 12(8):796-803. 10.1038/ni.2057, 21706005.
32. Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, Mück C, Laschober GT. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 2010, 9(2):296.
33. Akao Y, Nakagawa Y, Iio A, Naoe T. Role of microRNA-143 in Fas- mediated apoptosis in human T-cell leukemia jurkat cells. Leuk Res 2009, 33(11):1530-1538. 10.1016/j.leukres.2009.04.019, 19464056.
34. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L. Modulation of microRNA expression in human T- cell development: targeting of NOTCH3 by miR-150. Blood 2011, 117(26):7053-7062. 10.1182/blood-2010-12-326629, 21551231.
35. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley S. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5(8):e12132. 10.1371/journal.pone.0012132, 2920328, 20711463.
36. Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer 2010, 126(11):2553-2562.